Page last updated: 2024-08-21

vancomycin and sm-216601

vancomycin has been researched along with sm-216601 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Araki, N; Izumikawa, K; Kakeya, H; Kamihira, S; Kihara, R; Kohno, S; Morinaga, Y; Nakamura, S; Seki, M; Tsukamoto, K; Yamamoto, Y; Yanagihara, K	1
Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, K; McGhee, P	1
Fisher, JF; Llarrull, LI; Mobashery, S	1

Reviews

1 review(s) available for vancomycin and sm-216601

Article	Year
Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactams; Cell Wall; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Penicillin-Binding Proteins; Peptide Synthases; Staphylococcus aureus	2009

Article

Year

Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.

Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

Topics: Anti-Bacterial Agents; beta-Lactams; Cell Wall; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Penicillin-Binding Proteins; Peptide Synthases; Staphylococcus aureus

2009

Other Studies

2 other study(ies) available for vancomycin and sm-216601

Article	Year
Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Animals; Anti-Bacterial Agents; Blood-Borne Pathogens; Bronchopneumonia; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Humans; Lung; Male; Methicillin Resistance; Mice; Pneumonia, Staphylococcal; Specific Pathogen-Free Organisms; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance	2008
Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7 Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Vancomycin	2009

Article

Year

Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.

Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

Topics: Animals; Anti-Bacterial Agents; Blood-Borne Pathogens; Bronchopneumonia; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Humans; Lung; Male; Methicillin Resistance; Mice; Pneumonia, Staphylococcal; Specific Pathogen-Free Organisms; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance

2008

Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.

Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7

Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Vancomycin

2009